AFC-HD AMS Life Science Co Ltd

AFC-HD AMS Life Science Co Ltd maintains a liquidity position with a current ratio of 0.86, indicating a potential short-term liquidity risk, as its current liabilities exceed its current assets. The company's liquidity_fpt metric shows a negative net cash position after subtracting total debt, which is a key flag in its risk assessment. The price-to-book ratio of 0.84 suggests that the company's market value is below its book value, potentially indicating undervaluation or asset impairment concerns. In terms of profitability, the company's return on equity (ROE) of 9.61% is below the typical benchmark for the industry, suggesting that it is not generating strong returns for its shareholders. The return on assets (ROA) of 2.97% also indicates that the company is not efficiently utilizing its assets to generate profits. The debt-to-equity ratio of 1.6 highlights a relatively high level of leverage, which could increase financial risk, especially in a volatile market. The company operates in two business segments: Healthcare and Pharmaceutical. The Healthcare segment is engaged in the manufacture and sale of health foods and cosmetics, as well as OEM services, while the Pharmaceutical segment is involved in the production and sale of ethical and over-the-counter drugs. The company's geographic exposure is primarily concentrated in Japan, with no significant international revenue disclosed in the provided data. The company's growth trajectory appears to be modest, with no significant revenue growth reported in the latest financial snapshot. The company's free cash flow is negative at -1,107,171,000 JPY, which could limit its ability to reinvest in the business or return value to shareholders. The capital expenditure of -3,538,771,000 JPY indicates that the company is investing in its operations, but the negative free cash flow suggests that these investments are not yet generating positive returns. The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt suggests that the company may need to raise additional capital or refinance its debt in the near future. The dilution potential is low, as the number of shares outstanding is the same for both basic and diluted shares, indicating no significant dilution from stock options or convertible securities. Recent events and filings do not indicate any major changes in the company's operations or financial position. The company's latest actual EPS of 102.98 JPY and revenue of 32,655,020,000 JPY align with the financial snapshot, suggesting that the company's performance is consistent with analyst estimates.